Stereotactic body radiation therapy favors long-term overall survival in patients with lung metastases: Five-year experience of a single-institution

Chinese Medical Journal

Volumn 124, Issue 24, 2011, Pages 4132-4137

  Zhang, Ye ^a   Xiao, Jian Ping ^a   Zhang, Hong Zhi ^a   Yin, Wei Bo ^a   Hu, Yi Min ^a   Song, Yi Xin ^a   Zhang, Ke ^a   Liao, Zhong Xing ^b   Li, Ye Xiong ^a  

^a CANCER HOSPITAL   (China)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Hypo fractionated; Lung; Metastases; Prognosis; Stereotactic body radiation therapy

Indexed keywords

ADOLESCENT; AGED; CANCER CONTROL; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LONG TERM SURVIVAL; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; RADIATION DOSE; RETROSPECTIVE STUDY; REVIEW; RIB FRACTURE; STEREOTACTIC BODY RADIATION THERAPY; THERAPY EFFECT; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RADIOSURGERY; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84862935256     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.24.003     Document Type: Review

References (21)

1. DeVita VT, Hellman S, Rosenberg SA. Cancer: principles and practice of oncology. 5th ed. Philadelphia: Lippincott; 1997: 2523-2606.
2. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol 1995; 13: 8-10.
3. Pastorino U, Buyse M, Friedel G, Ginsberg RJ, Girard P, Goldstraw P, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997; 113: 37-49.
4. Yano T, Shoji F, Maehara Y. Current status of pulmonary metastasectomy from primary epithelial tumors. Surg Today 2009; 39: 91-97.
5. Abbas G Pennathur A, Landreneau RJ, Luketich JD. Radiofrequency and microwave ablation of lung tumors. J Surg Oncol 2009; 100: 645-650.
6. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303: 1070-1076.
7. Lo SS, Fakiris AJ, Chang EL, Mayr NA, Wang JZ, Papiez L, et al. Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol 2010; 7: 44-54.
8. Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009; 27: 1579-1584.
9. Guckenberger M, Joern W, Mueller G, Krieqer T, Baier K, Gabor M, et al. Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation. Int J Radiat Oncol Biol Phys 2009; 74: 47-54.
10. Okunieff P, Petersen AL, Philip A, Mlano MT, Katz AW, Boros L, et al. Seterotactic body radiation therapy for lung metastase. Acta Oncologica 2006; 45: 808-817.
11. Wu SX, Deng ML, Bao Y, Wang HY, Gao YH, Li FH, et al. Therapeutic analysis of stereotactic radiotherapy for 39 patients with lung metastasis. Chin J Cancer 2006; 25: 880-884.
12. Norihisa Y, Nagata Y, Takayama K, Matsuo Y, Sakamoto T, Sakamoto M, et al. Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys 2008; 72: 398-403.
13. Baschnagel A, Mangona VS, Robertson J. Lung metastases treated with image-guided stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2010; 78 Suppl 3: s529-s530.
14. Masciullo S, Masi L, Menichelli C. Image guided stereotactic radiotherapy for the treatment of lung oligometastatic patients. Int J Radiat Oncol Biol Phys 2010; 78 Suppl 3: s509-s510.
15. Xiao JP, Xu GZ, Zhang HZ, Yin WB. Stereotactic radiotherapy for pulmonary metastatic neoplasm-preliminary experience of 52 patients. Chin J Radiat Oncol (Chin) 2006; 15: 23-27.
16. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989; 62: 679-694.
17. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000; 92: 205-216.
18. Common Terminology Criteria for Adverse Events version 3.0 (CTCAE v 3.0), Cancer Therapy Evaluation Program 2003. (Accessed August 16, 2011 at: http://ctep.cancer.gov/reporting/ctc.html)
19. Dunlap NE, Cai J, Biedermann GB, Yang W, Benedict SH, Sheng K, et al. Chest wall volume receving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010; 76: 796-801.
20. Kawase T, Takeda A, Kunieda E, Kokubo M, Kamikubo Y, Ishibashi R, et al. Extrapulmonary soft tissue fibrosis resulting from hypofactionated stereotactic body radiotherapy for pulmonary nodular lesions. Int J Radiat Oncol Biol Phys 2009; 74: 349-354.
21. Forquer JA, Fakiris AJ, Timmerman RD, Lo SS, Perkins SM, McGarry RC, et al. Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites. Radiother Oncol 2009; 93: 408-413.